(PharmaNewsWire.Com, July 02, 2020 ) The rising adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and favorable reimbursement scenario in developed countries are the major factors driving the growth of Laparoscopic Surgery Market.
The report analyzes and studies the patient population affected with hernia in the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, and India. Along with patient population, the report studies the adoption of open and laparoscopic hernia repair surgeries and the adoption of tack and glue applicators for mesh fixation.
Based on the type of hernia repair surgery, open hernia repair surgery accounted for the largest market share in 2017. Open hernia repair does not require any advanced equipment and takes 25% lesser time than laparoscopy. This makes open hernia repair more cost effective. Moreover, this type of surgery is preferred for hernias that have been present for a long period of time.
Based on the type of mesh fixator, glue applicators are expected to register the highest growth rate in the forecast period. The cost effectiveness, reduction in surgery time, and lower pain associated with glue fixation are driving the adoption of glue in hernia mesh fixation.
The US accounted for the largest share of the hernia mesh repair surgery market in 2017. The large share of the US is attributed to the large patient population, increasing adoption of technologically advanced products, and presence of a well-established medical reimbursement policy in the country.
The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US).
Medtronic (Ireland): Medtronic is a multinational medical technology company that manufactures and markets products for alleviating pain and restoring health. The company’s products are used by hospitals, clinics, third-party healthcare providers, distributors, and other institutions (including governmental healthcare programs and group purchasing organizations).
Johnson & Johnson (US): Johnson & Johnson offers hernia repair products through its subsidiary Ethicon. The hernia repair and fixation segment offers absorbable strap fixation devices; open absorbable strap fixation devices; polypropylene hernia systems and plugs; hernia mesh, including absorbable lightweight mesh, soft polypropylene mesh, polypropylene mesh, and woven mesh; tissue separating mesh, including flexible composite mesh, surgical mesh, ventral patches, and open flexible composite mesh devices; and biologic mesh, including tissue matrix and acellular hydrated dermis.
Like J&J, Ethicon also has a diverse product portfolio, and more than 600 general surgical products of the company are listed in the US FDA. Most of these products have patent exclusivity in the US beyond 2020, which will help the company gain market exclusivity and ensure sustained revenue. Ethicon harnesses J&J’s worldwide infrastructure to sell its products. Ethicon also benefits through synergies with its parent company in R&D, technological knowhow, business strategies, and project implementation experience.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
